Allison Flammang, DO
Family Medicine · Creve Coeur, MONPI 1154760163
Payments from drug & device makers
Across 356 payments — averaging $16.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- AstraZeneca$671
- Novo Nordisk$592
- Lilly USA, LLC$394
- Pfizer$388
- GSK$327
- plus $2K from 25 others
What the payments were for
- Food & beverage$5,766100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 132 | $1,752 |
| AstraZeneca | 36 | $671 |
| Novo Nordisk | 33 | $592 |
| Lilly USA, LLC | 22 | $394 |
| Pfizer | 24 | $388 |
| GSK | 21 | $327 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 11 | $227 |
| Abbott | 10 | $172 |
| Boehringer Ingelheim | 6 | $115 |
| Otsuka America Pharmaceutical, Inc. | 7 | $113 |
| Amgen | 5 | $111 |
| Sanofi-aventis U.S. LLC | 4 | $102 |
| Axsome Therapeutics, Inc. | 5 | $82 |
| Phathom Pharmaceuticals, Inc. | 4 | $72 |
| Idorsia Pharmaceuticals US Inc | 5 | $72 |
| Exact Sciences | 3 | $66 |
| Supernus Pharmaceuticals, Inc. | 4 | $64 |
| Lundbeck LLC | 3 | $61 |
| Biotronik NRO, Inc. | 1 | $56 |
| Collegium Pharmaceutical, Inc. | 3 | $56 |
| Exeltis, USA Inc. | 2 | $38 |
| Bayer | 2 | $34 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $30 |
| Sanofi Pasteur Inc. | 2 | $29 |
| Tris Pharma Inc | 2 | $29 |
| Viiv Healthcare Company | 1 | $28 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $25 |
| Globus Medical | 1 | $23 |
| Verona Pharma, Inc. | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Amarin Pharma, Inc. | 1 | $14 |
How this compares
$5,778 in reported general payments places this provider in the 90th percentile of 2,203 family medicine providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 67 | $95,476 |
| OzempicSemaglutide | 73 | $89,045 |
| FarxigaDapagliflozin Propanediol | 35 | $35,289 |
| JardianceEmpagliflozin | 18 | $23,253 |
| TrulicityDulaglutide | 17 | $21,645 |
| JanuviaSitagliptin Phosphate | 11 | $12,707 |
| EliquisApixaban | 16 | $9,349 |
| ArexvyRsvpref3 Antigen/As01e/Pf | 29 | $7,352 |
| Gabapentin | 152 | $3,612 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 97 | $2,646 |
| Levothyroxine Sodium | 322 | $2,267 |
| Atorvastatin Calcium | 254 | $1,946 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 47 | $1,927 |
| Aripiprazole | 25 | $1,593 |
| SynthroidLevothyroxine Sodium | 20 | $1,453 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $394 | $117,12084 claims |
| Novo NordiskOzempic | $592 | $89,04573 claims |
| AstraZenecaFarxiga | $671 | $35,28935 claims |
| Boehringer IngelheimJardiance | $115 | $23,25318 claims |
| PfizerEliquis, Paxlovid | $388 | $10,68028 claims |
| GSKArexvy | $327 | $7,35229 claims |
| AbbVieSynthroid | $1,752 | $1,45320 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,203 family medicine providers in Missouri.
Other family medicine in Creve Coeur
- Timothy JenningsMaryland Heights$30.2M
- William HowittSpringfield$19.9M
- Rupal TrivediSaint Louis$10.6M
- Frederic PraterMaryland Heights$9.1M
- Leea ReedRogersville$7.9M
- Dennis MorrisonSpringfield$5.7M
- Luke van KirkSpringfield$5.6M
- Amy RobertsTown And Country$4M
- Scott KuennenKansas City$2.2M
- George CarrJefferson City$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.